Tech Company Financing Transactions
AgaMatrix Funding Round
AgaMatrix closed a $23.7 million Series C financing round on 12/28/2007. Investors included Ferrer Freeman & Co. and private investors.
Transaction Overview
Company Name
Announced On
12/28/2007
Transaction Type
Venture Equity
Amount
$23,700,000
Round
Series C
Investors
Ferrer Freeman & Co. (Lead Investor)
Proceeds Purpose
The company plans to use the proceeds to fund expansion in Europe and general operations.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
7C Raymond Ave.
Salem, NH 03079
USA
Salem, NH 03079
USA
Phone
Website
Email Address
Overview
AgaMatrix's WaveSense Dynamic Electrochemistry technology extracts a spectrum of information that was previously inaccessible with traditional electrochemical methods in blood glucose monitoring.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
John Alberico
Chief Financial Officer
Jackson McAdam
VP - Engineering
Chuck Johnson
VP - Human Resources
Cara Mottolo
VP - Regulatory Affairs
David Olsen
Browse more venture capital transactions:
Prev: 12/28/2007: Panraven venture capital transaction
Next: 12/31/2007: Stellaris venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to report on every notable VC transaction. VC investment data records on this site are sourced from news reports and company announcements. The information is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs